Deep Dive: FDA to revoke Red No. 3 authorization
January 15th 2025, the FDA announced that they would be revoking their authorizations for Red No. 3 in food and ingested drugs. The Lycored team comments on the situation.
Characterizing the effect of supplements on the phenotype of cultured macrophages from patients with age-related macular degeneration
May 30, 2024
Oral vitamin and mineral supplements reduce the risk of visual loss in age-related macular degeneration (AMD). However, the pathways that mediate this beneficial effect are poorly understood. Macrophages may exert oxidative, inflammatory, and angiogenic effects in the context of AMD. We aim to assess if oral supplements can modulate the macrophage phenotype in this disease.
File Type:
www
Categories:
Lutein
Continue reading
Lycomato Longevity and Cellular Aging Webinar 2024
In our latest webinar, Elizabeth Tarshish, PhD, Head of Scientific Value & Strategy at Lycored discusses Lycomato’s impact on cellular and mitochondrial health and how it promotes longevity through a...
A Personal Thank You from Shirley ❤️
Reflecting on my fourth year at Lycored, I'm filled with gratitude for our incredible journey together in 2024.
We're here for you
Interested in speaking directly with a member of our team?
Click below to get in touch.